Rubicon Inks European Distribution Pacts | GenomeWeb

NEW YORK (GenomeWeb) – Rubicon Genomics today said that it has signed a series of distribution agreements covering Europe in advance of the launch of its new sequencing preparation kits.

The distribution agreements were signed with Cambridge Bioscience for the UK and Ireland; Biozym Scientific for Germany and Austria; AB Analitica for Italy; Sopachem for the Benelux countries; Nordic Biolabs for Denmark and Sweden; Immuno Diagnostic for Finland; and YBUX for Romania, the Slovak Republic, and the Czech Republic.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.